Managing a Prolonged PTT > 100 Seconds
For a patient with a PTT > 100 seconds, administer protamine sulfate at a dose of 1 mg for every 100 units of heparin given in the previous 2-3 hours (maximum single dose 50 mg) to reverse heparin-induced anticoagulation. 1
Diagnostic Approach
First, determine the cause of the prolonged PTT:
Review medication history:
- Heparin therapy (most common cause of PTT > 100)
- Other anticoagulants
- Recent thrombolytic therapy
Check timing of last heparin dose:
Rule out other causes:
- Lupus anticoagulant
- Factor deficiencies
- Liver disease
- Disseminated intravascular coagulation (DIC)
- Laboratory error (artifactual prolongation) 2
Management Algorithm
If on Unfractionated Heparin (UFH):
If actively bleeding or requiring urgent procedure:
If not bleeding but PTT > 100:
If on Low Molecular Weight Heparin (LMWH):
- If bleeding:
- Administer protamine according to timing since last dose 1
- For enoxaparin given within 8 hours: 1 mg protamine per 1 mg enoxaparin
If due to Direct Thrombin Inhibitors (e.g., Argatroban):
- If PTT > 100 on argatroban:
If due to Acquired Hemophilia:
- If PTT > 100 with normal PT and bleeding:
Special Considerations
Laboratory error: Verify extremely prolonged PTT with manual method, as automated systems can sometimes misinterpret very short clotting times as very long ones 2
Lupus anticoagulant: If present, PTT may be unreliable for monitoring heparin therapy. Use anti-Xa levels instead 3
Heparin resistance: If requiring >35,000 units/day to achieve therapeutic PTT, consider switching to anti-Xa monitoring (target 0.3-0.6 IU/mL) 1
Heparin-induced thrombocytopenia (HIT): Monitor platelet count every other day during heparin therapy. If HIT suspected, stop heparin and switch to direct thrombin inhibitor 1
Pitfalls to Avoid
Don't assume all prolonged PTTs indicate bleeding risk - approximately 36% of prolonged PTTs are not associated with increased bleeding risk 4
Don't rely solely on PTT for monitoring in special populations - patients with lupus anticoagulant, liver disease, or factor deficiencies may have baseline elevated PTT 3
Don't ignore pre-analytical variables - poor sample collection or processing can cause falsely prolonged PTT 2
Don't overlook heparin resistance - some patients may require higher doses due to increased binding of heparin to plasma proteins 1
By following this structured approach, you can effectively manage patients with significantly prolonged PTT while minimizing complications related to both bleeding and thrombosis.